Aibotics Inc. (AIBT)
OTCMKTS · Delayed Price · Currency is USD
0.0009
-0.0004 (-30.77%)
May 5, 2026, 3:09 PM EST
Aibotics Market Cap
Aibotics has a market cap or net worth of $785.99 thousand as of May 5, 2026. Its market cap has increased by 387.72% in one year.
Market Cap
785.99K
Enterprise Value
1.81M
Revenue
2.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 21, 2021, Aibotics's market cap has decreased from 42.01M to 785.99K, a decrease of -98.13%. That is a compound annual growth rate of -52.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 785.99K | -35.43% |
| Dec 31, 2025 | 1.22M | 1,088.20% |
| Dec 30, 2024 | 102.44K | -57.02% |
| Dec 29, 2023 | 238.35K | -91.06% |
| Dec 30, 2022 | 2.67M | -91.49% |
| Dec 30, 2021 | 31.32M | -25.44% |
| Jan 21, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptimmune Therapeutics | 954.19K |
| Evofem Biosciences | 914.46K |
| Exousia Pro | 751.05K |
| SQZ Biotechnologies Company | 710.74K |
| Halberd | 709.94K |
| Emmaus Life Sciences | 589.44K |
| Bio-Path Holdings | 584.59K |
| Regenerative Medical Technology Group | 512.42K |